Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Shujing Biotechnology is a specialized biotechnology firm headquartered in Shanghai, China, dedicated to advancing high-throughput single-cell sequencing and spatial transcriptomics. The company offers an integrated technology platform, including the S-Cell system, which combines microfluidic chips and proprietary barcoding reagents to facilitate large-scale cellular analysis. Their product portfolio encompasses automated library preparation instruments and comprehensive bioinformatics pipelines designed for clinical and academic research. Shujing Bio's innovations aim to resolve cellular heterogeneity in complex diseases such as cancer and autoimmune disorders. The company serves as a significant domestic provider of genomic tools within the Chinese life sciences market, supporting precision medicine and drug discovery efforts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Shujing Biotechnology.